GLP-1 medications , or glucagon-like peptide-1 compounds, represent a truly development in how we treat diabetes mellitus . These new medications help imitating the body’s inherent GLP-1 hormone , which supports insulin release and reduces glucose release. Beyond blood sugar control , research indicate that GLP-1 receptor agonists may also provid